Acerus Pharmaceuticals Corporation (ASP) Fundamentals

Acerus Pharmaceuticals Corp is a specialty pharmaceutical company focused on the development, manufacture, marketing and distribution of branded products that improve patient experience, with a primary focus on the field of men's health. Its foundational product includes NATESTO, a testosterone therapy based on nasal gel technology. The company commercializes its products via its salesforce in the United States and Canada, and through a global network of licensed distributors in other territories.
SHARE INFORMATION
Market Cap$ 23,121,750
Shares Outstanding7,707,747
Float4,743,456
Percent Float61.55%
Short Interest824.00
Short Percent Float100.0%
Short Interest Ratio1.5288
Short Interest Date2022-07-15
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ -5,223,760
Latest Fiscal EPS$ -5.06
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions1
Institutional Holdings Date2020-04-30
Institutional Bought Previous 3 Months-
Institutional Holdings Percent0.0%
Institutional Sold Previous 3 Months-
Insider Holdings Date-
Insider Bought Previous 3 Months-
Insider Holdings Percent0.0
Insider Sold Previous 3 Months-
Insider Shares Owned2,963,794
TRADING INFO
52 Week High$ 10.00
52 Week Low$ 1.69
52 Week High Change$ -62.50
21 Day Moving Average$ 2.9581
21 Day Extended Moving Average$ 3.0126
50 Day Moving Average$ 3.1688
50 Day Extended Moving Average$ 3.4919
200 Day Moving Average$ 6.231
200 Day Extended Moving Average$ 5.7856
10 Day Average Volume278
20 Day Average Volume554
30 Day Average Volume451
50 Day Average Volume468
Alpha-0.004213
Beta1.185239
Standard Deviation0.343088
R20.021875
7 Day Price Change$ 0.00
7 Day Percent Change0.0%
21 Day Price Change$ 0.00
21 Day Percent Change0.0%
30 Day Price Change$ 0.13
30 Day Percent Change4.53%
Month to Date Price Change$ 0.00
Month to Date Percent Change0.0%
Quarter to Date Price Change$ -0.10
Quarter to Date Percent Change-3.23%
180 Day Price Change$ -5.00
180 Day Percent Change-62.5%
200 Day Price Change$ -4.00
200 Day Percent Change-57.14%
Year to Date Price Change$ -2.00
Year to Date Percent Change-40.0%

Acerus Pharmaceuticals Corporation (ASP) Key Ratios

PROFITABILITY
EBIT Margin-959.2%
EBITDA Margin-940.9%
Pre-Tax Profit Margin-858.1%
Profit Margin Count0.0%
Gross Margin55.9%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 2,518,716
Revenue Per Share$ 0.326777
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book-0.45
Total Debt To Equity2.61
Int Coverage-8.90
Current Ratio0.50
Leverage Ratio-1.90
Quick Ratio0.20
Long Term Debt To Capital0.68
VALUATION MEASURES
PE Ratio-1.00
Enterprise Value$ 64,002,412
Price to Sales9.1806
Price to Free Cash-1.10
PE High Last 5 Years7.70
Price To Book18.06
Price To Cash Flow595.00
PE Low Last 5 Years-2.20
Price to Tangible Book-0.45
MANAGEMENT EFFECTIVENESS
Receivables Turnover1.90
Invoice Turnover0.30
Assets Turnover0.10
Return Assets-93.76
Return on Equity415.09
Return on Capital-316.75

Acerus Pharmaceuticals Corporation (ASP) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorPricewaterhouseCoopers LLP
CEOEdward Gudaitis
Emplyoees14
Last AuditUE
CIK0001527246
IndustryDrug Manufacturers
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address7025 Langer Drive
Suite 205
Mississauga, ON L5N 0E8
Websitehttps://www.aceruspharma.com
Facsimile+1 905 569-1809
Telephone+1 289 326-5789
EmailIR@aceruspharma.com


Your Recent History
TSX
ASP
Acerus Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.